Michael Sherman
Vorsitzender bei CHIMERIX, INC.
Vermögen: 315 142 $ am 30.04.2024
Profil
Michael A.
Sherman's current jobs include being the Chairman at Chimerix, Inc. since 2023, the Director at The Children's Museum of Indianapolis, Inc. since 2012, and an Independent Director at Werewolf Therapeutics, Inc. since 2021.
His former jobs include being the President, Chief Executive Officer & Director at Endocyte, Inc. from 2017 to 2018, an Independent Director at BioSpecifics Technologies Corp.
in 2020, an Independent Director at Mead Johnson Nutrition Co. from 2015 to 2017, and Vice President-Finance & Strategic Planning at Guidant Corp.
from 2004 to 2006.
He also worked as a Principal at Eli Lilly & Co.Mr. Sherman's education includes an undergraduate degree from DePauw University and an MBA from the Tuck School of Business at Dartmouth.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CHIMERIX, INC.
0,40% | 31.03.2024 | 353 695 ( 0,40% ) | 315 142 $ | 30.04.2024 |
| 24.05.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Michael Sherman
| Unternehmen | Position | Beginn |
|---|---|---|
| CHIMERIX, INC. | Vorsitzender | 01.08.2023 |
| WEREWOLF THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 27.05.2021 |
| The Children's Museum of Indianapolis, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Sherman
| Unternehmen | Position | Ende |
|---|---|---|
| BIOSPECIFICS TECHNOLOGIES CORP. | Direktor/Vorstandsmitglied | 02.12.2020 |
| ENDOCYTE, INC. | Vorstandsvorsitzender | 21.12.2018 |
| MEAD JOHNSON NUTRITION CO | Direktor/Vorstandsmitglied | 15.06.2017 |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Finanzdirektor/CFO | 01.10.2006 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Ausbildung von Michael Sherman
| DePauw University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CHIMERIX, INC. | Health Technology |
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
| The Children's Museum of Indianapolis, Inc. | |
Mead Johnson Nutrition Co.
 Mead Johnson Nutrition Co. Food: Meat/Fish/DairyConsumer Non-Durables Mead Johnson Nutrition Co. produces infant and children's nutrition products. The firm offers Enfamil brand. The firm's product portfolio includes: children nutrition, nutrition for infants, for the dietary management of protein allergies, nutrition for preterm, low birth weight babies, for expecting or breastfeeding moms. The company was founded by Edward Mead Johnson, Sr. in 1905 and is headquartered in Chicago, IL. | Consumer Non-Durables |
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
